Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)

The subject of this publication is the conclusion of agreements under § 130a para. 8 SGB V for finished medicinal products with various active substances or combinations of active substances within the framework of a so-called "Open-House Model". Admission or the conclusion of the contract can take place at any time and under the same conditions. Individual contract negotiations will not be conducted. The earliest start date for the contract is 01.01.2027. Based on this, the maximum contract duration is 24 months. The contract ends on 31.12.2028, regardless of the start date of the contract. If, during the contract period, AOK Hessen carries out a tender for exclusive contracts in the form of an open procedure for the active substances, the contracts concluded within the framework of this publication will be terminated in accordance with the contractual provisions.